-
EP3801547
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3801547
| EP3801547 - METHODS OF TREATING CANCER [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 17.02.2023 Database last updated on 03.09.2024 | |
| Former | Request for examination was made Status updated on 12.03.2021 | ||
| Former | The international publication has been made Status updated on 07.12.2019 | Most recent event Tooltip | 17.02.2023 | Application deemed to be withdrawn | published on 22.03.2023 [2023/12] | Applicant(s) | For all designated states Pano Therapeutics, Inc. 59-639 Ke Iki Road Haleiwa, HI 96712 / US | [2022/23] |
| Former [2021/15] | For all designated states Pano Therapeutics, Inc. 449 O'Farrell Street, Apt 205 San Francisco, California 94102 / US | Inventor(s) | 01 /
FIENI, Francesca 449 O'Farrell Street, Apt. 205 San Francisco, California 94102 / US | [2021/15] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [N/P] |
| Former [2021/15] | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | Application number, filing date | 19812068.5 | 30.05.2019 | [2021/15] | WO2019US34566 | Priority number, date | US201862679643P | 01.06.2018 Original published format: US 201862679643 P | [2021/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019232156 | Date: | 05.12.2019 | Language: | EN | [2019/49] | Type: | A1 Application with search report | No.: | EP3801547 | Date: | 14.04.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 05.12.2019 takes the place of the publication of the European patent application. | [2021/15] | Search report(s) | International search report - published on: | US | 05.12.2019 | (Supplementary) European search report - dispatched on: | EP | 09.03.2022 | Classification | IPC: | A61K31/5377, A61K31/4412, A61K31/4965, A61K45/06, A61P35/00, A61P35/02 | [2022/14] | CPC: |
A61P35/02 (EP);
A61K31/4965 (EP,US);
A61K45/06 (EP,US);
A61K9/0019 (US);
A61K9/0053 (US);
A61P35/00 (EP,US)
| C-Set: |
A61K31/4965, A61K2300/00 (EP)
|
| Former IPC [2021/15] | A61K31/5377, A61K31/4412 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/15] | Title | German: | VERFAHREN ZUR BEHANDLUNG VON KREBS | [2021/15] | English: | METHODS OF TREATING CANCER | [2021/15] | French: | PROCÉDÉS DE TRAITEMENT DU CANCER | [2021/15] | Entry into regional phase | 30.12.2020 | National basic fee paid | 30.12.2020 | Search fee paid | 30.12.2020 | Designation fee(s) paid | 30.12.2020 | Examination fee paid | Examination procedure | 30.12.2020 | Examination requested [2021/15] | 16.08.2021 | Amendment by applicant (claims and/or description) | 11.10.2022 | Application deemed to be withdrawn, date of legal effect [2023/12] | 02.11.2022 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2023/12] | Fees paid | Renewal fee | 13.05.2021 | Renewal fee patent year 03 | 16.03.2022 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [E]WO2019232496 (UNIV CALIFORNIA [US]) [E] 1-15* the whole document *; | [X] - EPAND R F ET AL, "Reversal of intrinsic multidrug resistance in Chinese hamster ovary cells by amiloride analogs", BRITISH JOURNAL OF CANCER, NATURE PUBLISHING GROUP UK, LONDON, (19910101), vol. 63, no. 2, ISSN 0007-0920, pages 247 - 251, XP002967521 [X] 1,4,13,15 * page 251, column r, paragraph 2 * * page 250, column l, paragraph 2 - column r, paragraph 1 * * tables I-II * * the whole document * | International search | [A]US2006160746 (GORIN FREDRIC A [US], et al) [A] 1-3, 10-12* ; entire document *; | [A]US2012108494 (GORIN FREDRIC A [US], et al) [A] 1-3, 10-12 * ; entire document *; | [Y] - MURAI et al., "Production of new amilorides as potent inhibitors of mitochondrial respiratory complex I", Bioscience, Biotechnology, and Biochemistry, (20150303), vol. 79, pages 1061 - 1066, XP055658564 [Y] 1-3, 10-12 * ; Title, p1064 * DOI: http://dx.doi.org/10.1080/09168451.2015.1010479 | [Y] - URRA et al., "The Mitochondrial Complex(I)ty of Cancer", Frontiers in Oncology, (20170608), vol. 7, pages 1 - 8, XP055658568 [Y] 1-3, 10-12 * ; Title, Abstract, p3 * DOI: http://dx.doi.org/10.3389/fonc.2017.00118 | by applicant | - MUZ, Hypoxia, (20150000), vol. 3, pages 83 - 92 |